Form 4: Co-Diagnostics Director Richard Serbin Acquires 30,000 Shares
SEC Form 4
Director Richard Serbin acquired 30,000 shares of Co-Diagnostics, Inc. common stock on May 23, 2024.
Summary
- On May 23, 2024, Richard Serbin, a director of Co-Diagnostics, Inc., acquired 30,000 shares of common stock.
- The acquisition was made at a price of $0.00 per share.
- Following the transaction, Serbin directly owns 117,500 shares of Co-Diagnostics, Inc.
- The transaction involved the vesting of restricted stock units (RSUs).
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction (Form 4 filing) indicating a director's acquisition of shares through vesting of restricted stock units. It doesn't inherently suggest positive or negative implications for the company's performance.
Positives
- The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment, as insider buying is often viewed favorably.
Key Dates
| Date | Description |
|---|---|
| 07/07/2022 | 70,000 restricted stock units awarded, vesting in six equal installments every six months commencing on November 23, 2022. |
| 01/17/2023 | 40,000 restricted stock units awarded, vesting in six equal installments every six months commencing on May 23, 2023. |
| 06/12/2023 | 70,000 restricted stock units awarded, vesting in six equal installments every six months commencing on November 23, 2023. |
| 05/23/2024 | Richard Serbin acquired 30,000 shares of common stock through RSU vesting. |
| 05/28/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.